Catalent Newsroom

Barclays Maintains Catalent(CTLT.US) With Hold Rating, Maintains Target Price $63

Futu NewsNov 8 19:35

Analysts Have Conflicting Sentiments on These Healthcare Companies: Catalent (CTLT), Moderna (MRNA) and HCA Healthcare (HCA)

TipRanksNov 8 19:23

Jefferies Maintains Catalent(CTLT.US) With Hold Rating, Maintains Target Price $63.5

Futu NewsNov 6 21:40

Catalent's Biologics Underperformance and PCH Stability Lead to Hold Rating

TipRanksNov 6 21:20

Catalent Analyst Ratings

BenzingaSep 24 18:42

Baird Downgrades Catalent to Neutral From Outperform, Price Target Is $63.50

MT NewswiresSep 24 17:37

Baird Downgrades Catalent(CTLT.US) to Hold Rating, Maintains Target Price $63.5

Futu NewsSep 24 17:32

Hold Rating on Catalent Amid Deal Uncertainties and Conservative Financial Outlook

TipRanksSep 24 16:38

RBC Capital Reiterates Sector Perform on Catalent, Maintains $63.5 Price Target

BenzingaJul 11 23:02

Catalent Analyst Ratings

BenzingaJul 11 23:00

Analysts Conflicted on These Healthcare Names: Lantheus (LNTH) and Catalent (CTLT)

TipRanksJul 11 18:41

Barclays Raises Catalent's Price Target to $63 From $47, Maintains Equalweight Rating

MT NewswiresJun 28 23:55

Catalent Analyst Ratings

BenzingaJun 28 23:43

Barclays Adjusts Catalent Price Target to $63 From $47

MT NewswiresJun 27 19:20

Catalent's Resilient Growth and Positive Outlook Reinforce Buy Rating

TipRanksMay 10 13:45

RBC Capital Sticks to Their Hold Rating for Catalent (CTLT)

TipRanksMay 9 18:49

Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target Is $48

MT NewswiresApr 12 22:37

Analysts Offer Insights on Healthcare Companies: Catalent (CTLT), Vertex Pharmaceuticals (VRTX) and Alkermes (ALKS)

TipRanksApr 12 13:50

Analysts Have Conflicting Sentiments on These Healthcare Companies: Catalent (CTLT), Alvotech (ALVO) and Immunocore Holdings (IMCR)

TipRanksApr 5 15:55

Catalent Analyst Ratings

BenzingaApr 4 22:30